STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION (Tables)
|
6 Months Ended |
Jun. 30, 2026 |
|---|
| Equity [Abstract] |
|
| Schedule of Restricted Stock and Restricted Stock Unit, Activity |
The following table summarizes activity related to the Company’s restricted stock awards for the six months ended June 30, 2026:
| | | | | | | | | | | | | Restricted Stock Awards | | Number of Shares | | Weighted Average Grant Date Fair Value | | Nonvested as of December 31, 2025 | 285,053 | | $ | 0.08 | | | Granted | — | | | — | | Vested | (239,301) | | 0.01 | | | Forfeited | (2,132) | | — | | | Nonvested as of June 30, 2026 | 43,620 | | $ | 0.45 | |
The following table summarizes activity related to the Company’s RSUs for the six months ended June 30, 2026:
| | | | | | | | | | | | | Restricted Stock Units | | Number of Shares | | Weighted Average Grant Date Fair Value | | Nonvested as of December 31, 2025 | 7,217,790 | | $ | 9.14 | | | Granted | 3,608,010 | | 11.59 | | Vested | (1,555,336) | | 8.74 | | | Forfeited | (387,078) | | 11.60 | | | Nonvested as of June 30, 2026 | 8,883,386 | | $ | 10.27 | |
|
| Summary of Performance-Based Restricted Stock |
The following table summarizes activity related to the Company’s performance-based restricted stock units (“PRSU”) for the six months ended June 30, 2026:
| | | | | | | | | | | | | Number of Shares | | Weighted Average Grant Date Fair Value | | Nonvested as of December 31, 2025 | 801,292 | | | $ | 9.71 | | | Granted | 102,000 | | | 9.38 | | | Vested | — | | | — | | | Forfeited | (33,664) | | | 9.71 | | | Nonvested as of June 30, 2026 | 869,628 | | | $ | 9.67 | |
|
| Schedule of Information Related to Stock Options |
| | | | | | | | | | | | | | | | | | | Options | | Weighted Average Exercise Price | | Intrinsic Value (in thousands) | | Outstanding as of December 31, 2025 | 826,539 | | $ | 1.01 | | | $ | 8,573 | | | Granted | — | | | — | | | — | | | Exercised | (102,986) | | 3.87 | | | 678 | | | Forfeited | (29,415) | | 1.52 | | | 194 | | | Outstanding as of June 30, 2026 | 694,138 | | $ | 0.84 | | | $ | 4,545 | | | | | | | | | Exercisable as of June 30, 2026 | 473,487 | | $ | 0.79 | | | $ | 3,116 | | | Exercisable and expected to vest at June 30, 2026 | 694,138 | | $ | 0.84 | | | $ | 4,545 | |
|
| Schedule of Stock-Based Compensation Expense |
The Company recorded stock-based compensation expense in the unaudited condensed consolidated statements of operations and comprehensive loss as follows (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | 2026 | | 2025 | | 2026 | | 2025 | | General and administrative | $ | 8,543 | | | $ | 2,061 | | | $ | 11,990 | | | $ | 3,885 | | | Research and development | 5,421 | | | 2,158 | | | 8,943 | | | 4,087 | | | Operations | 309 | | | 96 | | | 559 | | | 176 | | | Sales and marketing | 412 | | | 83 | | | 546 | | | 129 | | | Total stock-based compensation expense | $ | 14,685 | | | $ | 4,398 | | | $ | 22,038 | | | $ | 8,277 | |
|
| Schedule of Warrants |
The following is a summary of warrants as of June 30, 2026: | | | | | | | | | | | | | Warrants | | Weighted Average
Exercise Price | | Outstanding as of December 31, 2025 | 5,079,294 | | $ | 10.18 | | | Granted | — | | | — | | | Exercised | — | | | — | | | Forfeited | — | | | — | | | Outstanding as of June 30, 2026 | 5,079,294 | | $ | 10.18 | | | | | | | Exercisable as of June 30, 2026 | 5,079,294 | | $ | 10.18 | |
|